SCHEMBL9747671

SCHEMBL9747671

NCCCC[C@H](NC(=O)C(N)Cc1ccccc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ERAP2 Q6P179 3/20 0.65
LNPEP Q9UIQ6 3/20 0.65
MMP2 P08253 1/20 0.57
GNPAT O15228 1/20 0.57
ECE1 P42892 1/20 0.54
OPRK1 P41145 1/20 0.53
ERAP1 Q9NZ08 1/20 0.53
CTSC P53634 1/20 0.52
ALPI P09923 1/20 0.51
PKM P14618 1/20 0.51
PTGS1 P23219 1/20 0.51
XIAP P98170 1/20 0.51
SLC7A5 Q01650 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28540087 1.00 ERAP2 (0.65) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL1711485 1.00 ERAP2 (0.65) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL29382413 1.00 ERAP2 (0.65) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL170652 1.00 ERAP2 (0.65) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL29372662 1.00 ERAP2 (0.65) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL29356104 0.99 ERAP2 (0.64) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL29630365 0.97 ERAP2 (0.62) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL7120877 0.97 ERAP2 (0.62) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL1711765 0.96 GNPAT (0.63) ERAP2LNPEPMMP2GNPATECE1
SCHEMBL1711591 0.96 GNPAT (0.63) ERAP2LNPEPMMP2GNPATECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0514460-A1 ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF PROCYTE CORPORATION (US) 1992-11-25 EP disclosed
WO-1991012267-A1 ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF PROCYTE CORPORATION (US) 1991-08-22 WO disclosed